The Journal of Allergy and Clinical Immunology
Volume 117, Issue 5 , Pages 995-1000, May 2006

Validation of a β-agonist long-term asthma control scale derived from computerized pharmacy data

  • Michael Schatz, MD, MS

      Affiliations

    • From the Departments of Allergy San Diego
    • Corresponding Author InformationReprint requests: Michael Schatz, MD, MS, Department of Allergy, Kaiser-Permanente Medical Center, 7060 Clairemont Mesa Blvd, San Diego, CA 92111.
  • ,
  • Robert S. Zeiger, MD, PhD

      Affiliations

    • From the Departments of Allergy San Diego
  • ,
  • William M. Vollmer, PhD

      Affiliations

    • Center for Health Research (Portland)
  • ,
  • David Mosen, PhD

      Affiliations

    • Care Management Institute (Oakland), Kaiser-Permanente Medical Care Program
  • ,
  • Andrea J. Apter, MD, MSc

      Affiliations

    • Division of Allergy-Immunology, Department of Pulmonary and Critical Care Medicine, University of Pennsylvania School of Medicine, Philadelphia
  • ,
  • Thomas B. Stibolt, MD

      Affiliations

    • Care Management Institute (Oakland), Kaiser-Permanente Medical Care Program
  • ,
  • Albin Leong, MD

      Affiliations

    • From the Departments of Allergy Sacramento
  • ,
  • Michael S. Johnson, MS

      Affiliations

    • Care Management Institute (Oakland), Kaiser-Permanente Medical Care Program
  • ,
  • Guillermo Mendoza, MD

      Affiliations

    • From the Departments of Allergy Vacaville
  • ,
  • E. Francis Cook, ScD

      Affiliations

    • Department of Epidemiology, Harvard School of Public Health, Boston

Received 19 December 2005; received in revised form 26 January 2006; accepted 31 January 2006. published online 05 April 2006.

San Diego, Sacramento, Vacaville, and Oakland, Calif, Portland, Ore, Philadelphia, Pa, and Boston, Mass

Background

Asthma control has been defined clinically by using validated tools, but an asthma control scale using administrative data has not been reported.

Objective

We sought to validate a β-agonist asthma control scale derived from administrative data.

Methods

Surveys that included validated asthma symptom and control tools were completed by a random sample of 2250 health maintenance organization members aged 18 to 56 years with persistent asthma. Linked computerized pharmacy data provided β-agonist canister and oral corticosteroid dispensings. The proposed 4-level asthma control scale was based on the number of short-acting β-agonist canisters dispensed in 12 months. Construct validity and predictive validity were assessed.

Results

For construct validity, factor analysis showed significant loading of the β-agonist scale on the symptom control factor, and the β-agonist scale was significantly related to the validated asthma control and symptom scales (r = 0.31, P < .0001). For predictive validity, each progressive level of the proposed β-agonist control scale was associated with an increased risk of subsequent asthma hospitalizations or emergency department visits and oral corticosteroid use, independent of prior use.

Conclusion

A scale based on the number of β-agonists dispensed in a 1-year period and derived from administrative data reflects asthma symptom control over that period of time. This scale can help identify patients who are at risk for future acute asthma health care use.

Clinical implications

This information can be used in population management and by clinicians to assess long-term asthma control and identify patients who need intervention to prevent future morbidity.

Key words: Asthma, asthma control, β-agonists, administrative data, asthma population management

Abbreviations used: AOMS, Asthma Outcomes Monitoring System, AQLQ, Mini Asthma Quality of Life Questionnaire, ATAQ, Asthma Therapy Assessment Questionnaire, ED, Emergency department, HEDIS, Health Plan Employer Data and Information Set

 

 Supported by the Kaiser-Permanente Care Management Institute, Oakland, Calif.Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(06)00327-7

doi:10.1016/j.jaci.2006.01.053

The Journal of Allergy and Clinical Immunology
Volume 117, Issue 5 , Pages 995-1000, May 2006